EMAIL THIS PAGE TO A FRIEND

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

Antiangiogenic potential of grape stem extract through inhibition of vascular endothelial growth factor expression.


PMID 25554988

Abstract

The aim of the present study was to investigate the antiangiogenic potential of a grape stem extract against tube formation by human endothelial cells (EA.hy926). The results showed that at low and non-cytotoxic concentrations (50 and 100 μg/ml) the grape stem extract inhibited tube formation, indicating a possible antiangiogenic activity. Moreover, the results showed that this extract inhibited the expression levels of vascular endothelial growth factor (VEGF), one of the most potent proangiogenic factors, suggesting that the tube formation inhibition by the extract may be exerted through inhibition of VEGF levels. Since it is well established that VEGF prevents apoptosis, the previous finding was further supported by the fact that the grape stem extract induced apoptosis in EA.hy926 cells. Furthermore, it was shown that the extract treatment did not change the levels of the proangiogenic molecules hypoxia inducible factor 1 alpha (HIF-1α) and cyclooxygenase-1 (COX-1). Therefore, these findings indicate that the grape stem extract reduces VEGF levels through mechanisms that may be HIF-1α- and COX-1-independent. The present study is the first showing that grape stem extracts possess antiangiogenic potential. Thus, our findings suggest that since grape stem extracts possess important bioactivities such as antiangiogenic potential, they could be exploited for developing chemopreventive and anticancer agents, while simultaneously protecting the environment through the use of a harmful waste.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

03910590
(±)-Catechin hydrate, primary reference standard
C15H14O6 · xH2O
43412
(+)-Catechin, analytical standard
C15H14O6
E1753
(−)-Epicatechin, ≥90% (HPLC)
C15H14O6
68097
(−)-Epicatechin, analytical standard
C15H14O6
E4018
(−)-Epicatechin, ≥98% (HPLC), from green tea
C15H14O6
60018
Caffeic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
C9H8O4
60020
Caffeic acid, purum, ≥95.0% (HPLC)
C9H8O4
409332
Cobalt(II) chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
Cl2Co
449776
Cobalt(II) chloride, anhydrous, beads, −10 mesh, 99.9% trace metals basis
Cl2Co
03940590
Epicatechin, primary reference standard
C15H14O6
Y0001013
Ferulic acid, European Pharmacopoeia (EP) Reference Standard
C10H10O4
91215
Gallic acid, certified reference material, TraceCERT®
C7H6O5
96353
Kaempferol, analytical standard
C15H10O6
00550580
Kaempferol, primary reference standard
C15H10O6
60010
Kaempferol, ≥97.0% (HPLC)
C15H10O6
K0133
Kaempferol, ≥90% (HPLC), powder
C15H10O6
C9008
p-Coumaric acid, ≥98.0% (HPLC)
C9H8O3
PHR1488
Quercetin, Pharmaceutical Secondary Standard; Certified Reference Material
C15H10O7 · xH2O
1592409
Quercetin, United States Pharmacopeia (USP) Reference Standard
C15H10O7 · 2H2O
S6881
Syringic acid, ≥95%
C9H10O5
63627
Syringic acid, analytical standard
C9H10O5
46278
trans-Ferulic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
C10H10O4
W518301
trans-Ferulic acid, ≥99%
C10H10O4
128708
trans-Ferulic acid, 99%
C10H10O4
52229
trans-Ferulic acid, certified reference material, TraceCERT®
C10H10O4
55823
trans-p-Coumaric acid, analytical standard
C9H8O3